Cargando…
Histamine‐2 (H(2)) antagonists can be safely removed from standard paclitaxel premedication regimens
AIMS: The aim of this study is to investigate the rates of hypersensitivity reactions (HSRs) in patients receiving paclitaxel chemotherapy, with and without a histamine‐2 (H(2)) antagonists. METHOD: This prospective, multi‐centre, cohort study compared patients receiving paclitaxel treated with prem...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9545865/ https://www.ncbi.nlm.nih.gov/pubmed/35470452 http://dx.doi.org/10.1111/bcp.15363 |